LWANC
VIVO

Laurel Wealth Advisors (North Carolina)’s Meridian Bioscience Inc VIVO Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-150
Closed -$4K – 769
2021
Q1 		$4K Buy
+150
New +$3.57K ﹤0.01% 545

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Laurel Wealth Advisors (North Carolina)'s VIVO Position: Q2 2021 in Review

Laurel Wealth Advisors (North Carolina) sold out of Meridian Bioscience Inc (VIVO) in Q2 2021, closing a stake of 150 shares — an estimated $4K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in VIVO in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

  • Laurel Wealth Advisors (North Carolina) reported no remaining Meridian Bioscience Inc position as of Q2 2021 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 150 Meridian Bioscience Inc shares in Q2 2021, an estimated $4K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in Meridian Bioscience Inc in Q1 2021 and held it in 1 quarter.
  • Laurel Wealth Advisors (North Carolina)'s Meridian Bioscience Inc position peaked at $4K in Q1 2021.
  • 189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q2 2021, filed 2 Aug 2021.